Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
$1.88−0.11 (-5.53%)
Close on Nov 13, 2026Market cap $69.14MP/E –Yield –
Fortress Biotech total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Fortress Biotech's total debt was $18.08M at Sep 30, 2026. For fiscal 2025 it was $52.42M, down 9.6% from the year before. Over ten years it grew 8.5% a year on average. The highest annual figure on record is $91.73M in fiscal 2022.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $52.42M | -9.6% |
| FY2024 | Dec 31, 2024 | $57.96M | -4.8% |
| FY2023 | Dec 31, 2023 | $60.86M | -33.7% |
| FY2022 | Dec 31, 2022 | $91.73M | +113.6% |
| FY2021 | Dec 31, 2021 | $42.94M | -16.9% |
| FY2020 | Dec 31, 2020 | $51.68M | -33.3% |
| FY2019 | Dec 31, 2019 | $77.44M | +28.2% |
| FY2018 | Dec 31, 2018 | $60.43M | +54.1% |
| FY2017 | Dec 31, 2017 | $39.21M | +74.1% |
| FY2016 | Dec 31, 2016 | $22.53M | -2.8% |
| FY2015 | Dec 31, 2015 | $23.17M | +65.5% |
| FY2014 | Dec 31, 2014 | $14.00M | +99.6% |
| FY2013 | Dec 31, 2013 | $7.02M | -43.3% |
| FY2012 | Dec 31, 2012 | $12.39M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.08M | -62.2% |
| Q2 FY2026 | Jun 30, 2026 | $34.60M | -30.8% |
| Q1 FY2026 | Mar 31, 2026 | $36.88M | -34.6% |
| Q4 FY2025 | Dec 31, 2025 | $52.42M | -9.6% |
| Q3 FY2025 | Sep 30, 2025 | $47.77M | -9.0% |
| Q2 FY2025 | Jun 30, 2025 | $50.03M | -25.3% |
| Q1 FY2025 | Mar 31, 2025 | $56.38M | -8.2% |
| Q4 FY2024 | Dec 31, 2024 | $57.96M | -4.8% |
| Q3 FY2024 | Sep 30, 2024 | $52.47M | +14.6% |
| Q2 FY2024 | Jun 30, 2024 | $67.01M | +47.8% |
| Q1 FY2024 | Mar 31, 2024 | $61.42M | -31.8% |
| Q4 FY2023 | Dec 31, 2023 | $60.86M | -33.7% |
| Q3 FY2023 | Sep 30, 2023 | $45.79M | -49.8% |
| Q2 FY2023 | Jun 30, 2023 | $45.33M | -47.0% |
| Q1 FY2023 | Mar 31, 2023 | $90.00M | +5.8% |
| Q4 FY2022 | Dec 31, 2022 | $91.73M | +113.6% |
| Q3 FY2022 | Sep 30, 2022 | $91.17M | +114.2% |
| Q2 FY2022 | Jun 30, 2022 | $85.61M | +63.8% |
| Q1 FY2022 | Mar 31, 2022 | $85.06M | +63.6% |
| Q4 FY2021 | Dec 31, 2021 | $42.94M | -16.9% |
| Q3 FY2021 | Sep 30, 2021 | $42.57M | -17.2% |
| Q2 FY2021 | Jun 30, 2021 | $52.26M | -18.5% |
| Q1 FY2021 | Mar 31, 2021 | $51.99M | -26.6% |
| Q4 FY2020 | Dec 31, 2020 | $51.68M | -33.3% |
| Q3 FY2020 | Sep 30, 2020 | $51.39M | -25.0% |
| Q2 FY2020 | Jun 30, 2020 | $64.16M | -13.7% |
| Q1 FY2020 | Mar 31, 2020 | $70.87M | -3.7% |
| Q4 FY2019 | Dec 31, 2019 | $77.44M | +28.2% |
| Q3 FY2019 | Sep 30, 2019 | $68.54M | +6.2% |
| Q2 FY2019 | Jun 30, 2019 | $74.31M | +1.2% |
| Q1 FY2019 | Mar 31, 2019 | $73.61M | +0.2% |
| Q4 FY2018 | Dec 31, 2018 | $60.43M | +54.1% |
| Q3 FY2018 | Sep 30, 2018 | $64.55M | +58.5% |
| Q2 FY2018 | Jun 30, 2018 | $73.46M | +87.0% |
| Q1 FY2018 | Mar 31, 2018 | $73.44M | +181.0% |
| Q4 FY2017 | Dec 31, 2017 | $39.21M | +74.1% |
| Q3 FY2017 | Sep 30, 2017 | $40.73M | – |
| Q2 FY2017 | Jun 30, 2017 | $39.27M | – |
| Q1 FY2017 | Mar 31, 2017 | $26.14M | – |
| Q4 FY2016 | Dec 31, 2016 | $22.53M | – |
See a number that looks wrong?